down arrow

Alto Neuroscience, Inc.

  • Market Cap: N/A
  • Industry: Miscellaneous
  • ISIN: US02157Q1094
USD
19.45
1.26 (6.93%)

Dec 18

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

17.4019.97

52 Week

1.6019.97
Valuation
Technical
Day's Volume

CASH

716.97 k

Shareholding (Mar 2025)

FII

11.76%

Held by 29 FIIs

DII

60.17%

Held by 27 DIIs

Promoter

4.26%

How big is Alto Neuroscience, Inc.?

22-Jun-2025

As of Jun 18, Alto Neuroscience, Inc. has a market capitalization of 60.37 million and reported net sales of 0.00 million with a net profit of -63.18 million over the last four quarters. As of Dec 24, the company's shareholder's funds were 151.46 million, and total assets amounted to 177.54 million.

As of Jun 18, Alto Neuroscience, Inc. has a market capitalization of 60.37 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 0.00 million for the latest four quarters, with a consolidated net profit of -63.18 million during the same period.<BR><BR>As of Dec 24, the company's shareholder's funds were 151.46 million, and total assets amounted to 177.54 million.

Read More

What does Alto Neuroscience, Inc. do?

22-Jun-2025

Alto Neuroscience, Inc. is a micro-cap company in the miscellaneous industry, currently reporting a net profit loss of $15 million and a market cap of $60.37 million. Key metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of -44.87%.

Overview:<BR>Alto Neuroscience, Inc. operates in the miscellaneous industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Net Profit: -15 Million (Quarterly Results - Mar 2025)<BR>Market Cap: USD 60.37 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making)<BR>Industry P/E: NA<BR>Dividend Yield: 0.00%<BR>Debt Equity: -1.00<BR>Return on Equity: -44.87%<BR>Price to Book: 0.43<BR><BR>Contact Details:<BR>Details: No Company Details Available<BR>Registrar Address: Not available.

Read More

Is Alto Neuroscience, Inc. technically bullish or bearish?

20-Sep-2025

As of September 11, 2025, Alto Neuroscience, Inc. has shifted to a bullish trend, supported by positive moving averages and Bollinger Bands, despite a bearish weekly RSI, while outperforming the S&P 500 with returns of 4.58% and 20.53% over the past week and month, respectively.

As of 11 September 2025, the technical trend for Alto Neuroscience, Inc. has changed from sideways to bullish. The current technical stance is bullish, driven by a daily bullish moving average, weekly bullish Bollinger Bands, and a mildly bullish MACD on the weekly timeframe. However, the weekly RSI is bearish, indicating some short-term weakness. The company has outperformed the S&P 500 over the past week and month, with returns of 4.58% and 20.53% respectively, compared to 1.05% and 2.33% for the index.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 105 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.01

stock-summary
Return on Equity

-51.88%

stock-summary
Price to Book

0.85

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-18 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
373.24%
0%
373.24%
6 Months
756.83%
0%
756.83%
1 Year
434.34%
0%
434.34%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Alto Neuroscience, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-7.60%
EBIT Growth (5y)
-254.52%
EBIT to Interest (avg)
-37.18
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.00
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.50
EV to EBIT
0.99
EV to EBITDA
1.00
EV to Capital Employed
-69.15
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-44.87%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 23 Schemes (23.82%)

Foreign Institutions

Held by 29 Foreign Institutions (11.76%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -10.62% vs -83.91% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-18.60",
          "val2": "-18.20",
          "chgp": "-2.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.30",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-17.70",
          "val2": "-16.00",
          "chgp": "-10.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -69.15% vs -31.05% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-68.10",
          "val2": "-37.40",
          "chgp": "-82.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.40",
          "val2": "1.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "0.50",
          "chgp": "-160.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-61.40",
          "val2": "-36.30",
          "chgp": "-69.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-18.60
-18.20
-2.20%
Interest
0.60
0.30
100.00%
Exceptional Items
-0.10
0.00
Consolidate Net Profit
-17.70
-16.00
-10.62%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -10.62% vs -83.91% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-68.10
-37.40
-82.09%
Interest
1.40
1.40
Exceptional Items
-0.30
0.50
-160.00%
Consolidate Net Profit
-61.40
-36.30
-69.15%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -69.15% vs -31.05% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Alto Neuroscience, Inc. stock-summary
stock-summary
Alto Neuroscience, Inc.
Miscellaneous
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."